RCM Accretive Health

LifePoint Health and R1 RCM Announce Partnership to Deliver Revenue Cycle Excellence and Enhance Patient Experience

LifePoint Health and R1 RCM Announce Partnership to Deliver Revenue Cycle Excellence and Enhance Patient Experience

BRENTWOOD, Tenn. and CHICAGO, Oct. 28, 2020 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leader in technology-enabled revenue cycle management (RCM) services to healthcare providers, and LifePoint Health, a national network of hospitals, post-acute services, outpatient centers and providers in more than 80 locations, have entered into a new revenue cycle management agreement that will make R1 the exclusive revenue cycle management partner for more than one-third of LifePoint hospitals. The comprehensive partnership is designed to enhance patient experience and streamline operations to meet the evolving needs of the health system now and into the future for the communities LifePoint serves.

LifePoint’s decision to consolidate and create an enterprise-wide strategy was driven by the company’s ongoing efforts to drive next-level revenue cycle performance, which will further enable the organization to focus its resources on what matters most – delivering high-quality patient care. R1 will deliver its fully integrated, purpose-built technology platform with proven operating methods and enterprise-wide analytics. Powered with intelligent automation and executed upon by a diverse and experienced team of RCM experts, R1’s end-to-end and EHR-agnostic revenue cycle solution is designed to integrate seamlessly into LifePoint’s infrastructure to drive greater efficiency and performance for the organization.

“Following an extensive evaluation process, we are honored to have been selected by LifePoint as a long-term revenue cycle partner and are committed to broadening the partnership as we work together to advance the organization’s revenue cycle capabilities,” said Joe Flanagan, president and chief executive officer at R1. “We look forward to delivering a solution that will improve LifePoint’s financial operations, enrich the patient experience and increase provider satisfaction.”

“R1’s robust technological capabilities combined with its focus on mission and strong commitment to LifePoint’s current revenue cycle employees make them the right partner for LifePoint,” said Rob Jay, executive vice president of integrated operations at LifePoint Health. “We look forward to working with R1 to further strengthen revenue cycle operations across our organization, create a more seamless patient financial process and ensure our hospitals can stay focused on providing high quality care for those we serve.”

About R1 RCM

R1 RCM is a leading provider of technology-enabled RCM services which transform and solve revenue cycle performance challenges across hospitals, health systems and group physician practices. R1’s proven and scalable operating models seamlessly complement a healthcare organization’s infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. To learn more, visit: .

About LifePoint Health

LifePoint Health® is a leading healthcare company dedicated to Making Communities Healthier®. Through its subsidiaries, it provides quality inpatient, outpatient and post-acute services close to home. LifePoint owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities across the country. It is the sole community healthcare provider in the majority of the non-urban communities it serves. More information about the company can be found at .

Forward Looking Statements

This press release includes statements that may constitute “forward-looking statements” and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as applicable. In particular, statements about future events and relationships, plans, future growth, and future performance, are forward-looking statements. These statements are often identified by the use of words such as “anticipate,” “believe,” “designed,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” “would,” and similar expressions or variations, although not all forward-looking statements contain these identifying words. These forward-looking statements are based on current expectations and projections about future events as of the date hereof and any forward-looking statements contained herein should not be relied upon as representing the views of R1 or LifePoint as of any subsequent date. Subsequent events and developments, including actual results or changes in the assumptions of R1 or LifePoint, may cause views to change. While either R1 or LifePoint may elect to update these forward-looking statements at some point in the future, neither company has the current intention of doing so. Although each of R1 and LifePoint believes that the expectations reflected in such forward-looking statements by them are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Should one or more of these risks and uncertainties materialize, or should underlying assumptions, projections, or expectations prove incorrect, actual results, performance, financial condition, or events may vary materially and adversely from those anticipated, estimated, or expected. Actual results and outcomes could differ materially from those included in these forward-looking statements as a result of various factors, including, but not limited to the factors discussed in the case of R1 under the heading “Risk Factors” in R1’s annual report on Form 10-K for the year ended December 31, 2019, R1’s quarterly reports on Form 10-Q, and any other periodic reports R1 files with the Securities and Exchange Commission.

Contacts:
 
Investor Relations

Atif Rahim

R1 RCM Inc.

312.324.5476

Media Relations

Natalie Joslin                

R1 RCM Inc.                

678.585.1206                





Michelle Augusty

LifePoint Health

615.920.7654



EN
28/10/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Accretive Health

 PRESS RELEASE

TowerBrook and CD&R Complete Acquisition of R1 RCM

TowerBrook and CD&R Complete Acquisition of R1 RCM R1 RCM Becomes Privately Held Company; Joe Flanagan Reappointed as CEO MURRAY, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (“R1”), a leader in automating revenue management for healthcare providers, today announced that investment funds affiliated with TowerBrook Capital Partners (“TowerBrook”) and Clayton, Dubilier & Rice (“CD&R”) have completed their previously announced acquisition of R1. On August 1, 2024, TowerBrook, CD&R and R1 announced that they had entered into a definitive merger agreement under which all outstanding ...

 PRESS RELEASE

R1 RCM Reports Third Quarter 2024 Results

R1 RCM Reports Third Quarter 2024 Results MURRAY, Utah, Nov. 05, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2024. Third Quarter 2024 Results: Revenue of $656.8 million, up $84.0 million or 14.7% compared to the same period last year.GAAP net loss of $19.9 million, compared to net income of $1.3 million in the same period last year.Adjusted EBITDA of $148...

 PRESS RELEASE

R1 RCM Reports Second Quarter 2024 Results

R1 RCM Reports Second Quarter 2024 Results MURRAY, Utah, Aug. 07, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended June 30, 2024. Second Quarter 2024 Results: Revenue of $627.9 million, up $67.2 million or 12.0% compared to the same period last year.GAAP net loss of $7.6 million, compared to net loss of $1.0 million in the same period las...

 PRESS RELEASE

R1 RCM to be Acquired by TowerBrook and CD&R for $8.9 Billion

R1 RCM to be Acquired by TowerBrook and CD&R for $8.9 Billion Stockholders to Receive $14.30 Per Share in Cash MURRAY, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice (“CD&R”), in an all-cash transaction with an enterprise value of approxi...

 PRESS RELEASE

R1 RCM Special Committee Provides Update on Evaluation of Strategic Al...

R1 RCM Special Committee Provides Update on Evaluation of Strategic Alternatives Sets Final Bid Deadline of July 31, 2024 MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the Securities and Exchange Commission on February 26, 2024, today announced it has set a final deadline for interested parties to sub...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch